Evidence map›Paper›PMID 25897234›Full record

ReviewNeuropsychiatric disease and treatment2015

Neuromodulation and antenatal depression: a review.

Deborah R Kim, Jessica L Snell, Grace C Ewing, John O'Reardon

Open access · goldAbstract readReview
In one paragraph

Review in Neuropsychiatric disease and treatment, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Deborah R KimDepartment of Psychiatry, Penn Center for Women's Behavioral Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Jessica L SnellDepartment of Psychiatry, Penn Center for Women's Behavioral Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
Grace C EwingDepartment of Psychiatry, Penn Center for Women's Behavioral Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.
John O'ReardonDepartment of Psychiatry, Rowan University, Rowan School of Medicine, Cherry Hill, NJ, USA.
Rowan University · US

Funding

Transcranial Magnetic Stimulation in Pregnant Women with Depressive DisorderK23MH092399 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI KIM, DEBORAH · 2011 to 2015
$886k
NIMH NIH HHS K23 MH092399
6 · The paper itself

Abstract

backgroundDepression during pregnancy affects 5%-8% of women. While the percentage of women in the US taking serotonin reuptake inhibitors during pregnancy has risen over the last decade, pregnant women continue to report that they prefer non-pharmacologic interventions.

objectiveWe review the literature regarding neuromodulation techniques for major depressive disorder during pregnancy. The rationale for their use in this population, new developments, and future directions are discussed.

methodsA literature search was conducted in PubMed Plus, Ovid Medline, and Embase to collect all articles on neuromodulation for the treatment of depression during pregnancy. Key search words included electroconvulsive therapy, transcranial magnetic stimulation, deep brain stimulation, transcranial direct current stimulation, neuromodulation, depression, and pregnancy. Given the sparse literature, all articles from 1960 to 2014 that addressed the use of neuromodulation in pregnancy were included.

conclusionThe data support the use of electroconvulsive therapy in all trimesters of pregnancy for major depressive disorder. New data are emerging for the use of transcranial magnetic stimulation in pregnancy, which is likely safe, but more data are needed before it can be recommended as a primary treatment modality during pregnancy. Other neuromodulation techniques have not been well studied in this population.

Indexed as

antenatal depressiondepressionelectroconvulsive therapyperinatalpregnancytranscranial magnetic stimulation

Identifiers

PMID25897234
PMCPMC4397922
OpenAlexW2012044656

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.